Translating pharmacogenomics: challenges on the road to the clinic. by Jesse J Swen, Tom W Huizinga, Hans Gelderblom, Elisabeth G E de Vries, Willem J J Assendelft, Julia Kirchheiner, Henk-Jan Guchelaar

Get full text

Laboratory and Neuroimaging Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: Where Do We Stand, Where To Go? by César Magro-Checa, César Magro-Checa, Gerda M. Steup-Beekman, Tom W. Huizinga, Mark A. van Buchem, Mark A. van Buchem, Itamar Ronen

Get full text

OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic Sclerosis by Miki Takata, Elena Pachera, Mojca Frank-Bertoncelj, Anastasiia Kozlova, Astrid Jüngel, Michael L. Whitfield, Shervin Assassi, Maurizio Calcagni, Jeska de Vries-Bouwstra, Tom W. Huizinga, Fina Kurreeman, Gabriela Kania, Oliver Distler

Get full text

Validation of the adjusted multi-biomarker disease activity score as a prognostic test for radiographic progression in rheumatoid arthritis: a combined analysis of multiple studies by Jeffrey R. Curtis, Michael E. Weinblatt, Nancy A. Shadick, Cecilie H. Brahe, Mikkel Østergaard, Merete Lund Hetland, Saedis Saevarsdottir, Megan Horton, Brent Mabey, Darl D. Flake, Rotem Ben-Shachar, Eric H. Sasso, T. W. Huizinga

Get full text

Genetic variation of the Fc gamma receptor 3B gene and association with rheumatoid arthritis. by Rute B Marques, Mohamed M Thabet, Stefan J White, Jeanine J Houwing-Duistermaat, Aleida M Bakker, Gert-Jan Hendriks, Alexandra Zhernakova, Tom W Huizinga, Annette H van der Helm-van Mil, Rene E Toes

Get full text